SuperworthArtivion EPS AORT
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$0.07
- Latest quarter, Q2 FY26
- −$0.28
- −1033% on a year earlier
- Fiscal year 2025
- $0.20
Artivion's earnings per share was −$0.07 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.28, down 1033% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.20 | n/a |
| FY2024 | −$0.31 | n/a |
| FY2023 | −$0.75 | n/a |
| FY2022 | −$0.48 | n/a |
| FY2021 | −$0.39 | n/a |
| FY2020 | −$0.45 | −1225% |
| FY2019 | $0.04 | n/a |
| FY2018 | −$0.08 | −180% |
| FY2017 | $0.10 | −70% |
| FY2016 | $0.33 | +154% |
| FY2015 | $0.13 | −50% |
| FY2014 | $0.26 | −54% |
| FY2013 | $0.56 | +93% |
| FY2012 | $0.29 | +12% |
| FY2011 | $0.26 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.28 | −1033% | −$0.07 | |
| Q1 FY26 | $0.03 | n/a | $0.24 | |
| Q4 FY25 | $0.05 | n/a | $0.20 | |
| Q3 FY25 | $0.13 | n/a | −$0.24 | |
| Q2 FY25 | $0.03 | n/a | −$0.42 | |
| Q1 FY25 | −$0.01 | −106% | −$0.50 | |
| Q4 FY24 | −$0.39 | n/a | −$0.31 | |
| Q3 FY24 | −$0.05 | n/a | −$0.02 | |
| Q2 FY24 | −$0.05 | n/a | −$0.21 | |
| Q1 FY24 | $0.18 | n/a | −$0.24 | |
| Q4 FY23 | −$0.10 | −300% | −$0.75 | |
| Q3 FY23 | −$0.24 | n/a | −$0.60 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Artivion's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| AORTArtivion | −$0.07 | |
| STAAStaar Surgical | $0.07 | |
| IRMDIradimed | $1.79 | +10% a year |
| BVSBioventus | $0.77 | |
| CDRECadre | $0.81 | −14% a year |
| EYENational Vision | $0.61 | |
| MOVMovado | $1.80 | +137% a year |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| INSPInspire Medical Systems | $4.62 | +166% a year |
| MDXGMimedx | $0.04 | −81% a year |
| UFPTUFP Technologies | $9.28 | +8% a year |
| Peer median | $1.30 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Artivion
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.